Susquehanna International Group, LLP Absci Corp Call Options Transaction History

Susquehanna International Group, LLP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.97 - $4.49 $12,474 - $18,858	4,200 Added 2.93%	147,500 $563,000
Q2 2024 Aug 15, 2024	SELL	$2.92 - $6.58 $709,560 - $1.6 Million	-243,000 Reduced 62.9%	143,300 $441,000
Q1 2024 May 07, 2024	BUY	$3.41 - $5.74 $871,255 - $1.47 Million	255,500 Added 195.34%	386,300 $2.19 Million
Q4 2023 Feb 14, 2024	BUY	$1.15 - $4.79 $132,825 - $553,245	115,500 Added 754.9%	130,800 $549,000
Q3 2023 Nov 14, 2023	SELL	$1.28 - $2.41 $196,608 - $370,176	-153,600 Reduced 90.94%	15,300 $20,000
Q2 2023 Aug 11, 2023	SELL	$1.17 - $2.03 $32,057 - $55,621	-27,400 Reduced 13.96%	168,900 $256,000
Q1 2023 May 16, 2023	SELL	$1.58 - $3.41 $93,536 - $201,872	-59,200 Reduced 23.17%	196,300 $343,000
Q4 2022 Feb 14, 2023	BUY	$2.0 - $3.58 $43,800 - $78,402	21,900 Added 9.38%	255,500 $536,000
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.83 $196,175 - $321,195	66,500 Added 39.8%	233,600 $731,000
Q2 2022 Aug 15, 2022	SELL	$3.13 - $8.83 $86,075 - $242,825	-27,500 Reduced 14.13%	167,100 $555,000
Q1 2022 May 16, 2022	BUY	$5.87 - $9.46 $1.14 Million - $1.84 Million	194,600 New	194,600 $1.64 Million

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $309M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.